Publication | Open Access
Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia
508
Citations
39
References
2001
Year
BL22 can induce complete remissions in patients with hairy-cell leukemia that is resistant to treatment with purine analogues.
| Year | Citations | |
|---|---|---|
Page 1
Page 1